Iron supplementation and 2-unit red blood cell apheresis: A randomized, double-blind, placebo-controlled study

Transfusion

Volumn 44, Issue 10, 2004, Pages 1463-1467

  Radtke, Hartmut ^a   Mayer, Beate ^b   Röcker, Lothar ^b   Salama, Abdulgabar ^b   Kiesewetter, Holger ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZARONE; FERRITIN; FERROUS ION; HEMOGLOBIN; PLACEBO;

ADULT; APHERESIS; ARTICLE; BLOOD DONOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; ERYTHROCYTE; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; IRON BLOOD LEVEL; IRON DEPLETION; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; UTILIZATION REVIEW;

ANEMIA, IRON-DEFICIENCY; BLOOD COMPONENT REMOVAL; BLOOD DONORS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ERYTHROCYTE TRANSFUSION; FERRITINS; HEMOGLOBINS; IRON; PLACEBOS;

EID: 4844225650     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.04045.x     Document Type: Article

References (22)

1. Shi PA, Ness PM. Two-unit red cell apheresis and its potential advantages over traditional whole-blood donation. Transfusion 1999;39:218-25.
2. Smith KJ, James DS, Hunt WC, et al. A randomized, double-blind comparison of donor tolerance of 400 mL, 200 mL, and sham red cell donation. Transfusion 1996;36:674-80.
3. Sherman LA, Lippmann MB, Ahmed P, Buchholz DH. Effect on cardiovascular function and iron metabolism of the acute removal of 2 units of red cells. Transfusion 1994;34:573-7.
4. Axelrod FB, Cation P, Beeler SA. A comparison of postdonation reaction in 2 unit automated red cell apheresis collection using the Haemonetics MCS+ with 1 unit manual whole blood collection in autologous donors. Transfusion 1995;35(Suppl):65S.
5. Schmidt AL, Handels J, Wieland M, Strauss RG. Collection of two unit autologous or allogeneic red blood cells by apheresis using Haemonetics MCS+. J Clin Apheresis 1997;12:41.
6. Scott E, Gilcher RO, Bemiller LS, et al. Apheresis collection of 2 units of allogeneic red cells: intra- and post-donation events. Transfusion 1997;37(Suppl):67S.
7. Högler W, Mayer W, Messmer C, et al. Prolonged iron depletion after allogeneic 2-unit RBC apheresis. Transfusion 2001;41:602-5.
8. Finch CA, Cook JD, Labbe RF, Culala M. Effect of blood donation on iron stores as evaluated by serum ferritin. Blood 1977;50:441-7.
9. Simon TL, Garry PJ, Hooper EM. Iron stores in blood donors. JAMA 1981;245:2038-43.
10. Alvarez-Ossorio L, Kirchner H, Klüter H, Schlenke P. Low ferritin levels indicate the need for iron supplementation: strategy to minimize iron-depletion in regular blood donors. Transfusion Med 2000;10:107-12.
11. Gordeuk VR, Brittenham GM, Hughes MA, Keating LJ. Carbonyl iron for short-term supplementation in female blood donors. Transfusion 1987;27:80-5.
12. Gordeuk VR, Brittenham GM, Bravo J, et al. Prevention of iron deficiency with carbonyl iron in female blood donors. Transfusion 1990;30:239-45.
13. Simon TL, Hunt WC, Garry PJ. Iron supplementation for menstruating female blood donors. Transfusion 1984;24:469-72.
14. Cable RG, Morse EE, Keltonic J, et al. Iron supplementation in female blood donors deferred by copper sulfate screening. Transfusion 1988;28:422-6.
15. Twisk JWR. Applied longitudinal data analysis for epidemiology. Cambridge: Cambridge University Press, 2003.
16. Bianco C, Brittenham G, Gilcher RO, et al. Maintaining iron balance in women blood donors of childbearing age: summary of a workshop. Transfusion 2002;42:798-805.
17. Skikne B, Lynch S, Borek D, Cook J. Iron and blood donation. Clin Haematol 1984;13:271-87.
18. Magnusson B, Sölvell L, Arvidsson B, Siösteen C. Iron absorption during iron supplementation in blood donors. Scand J Haematol 1975;14:337-46.
19. McLeod BC, Price TH, Owen H, et al. Frequency of immediate adverse effects associated with apheresis donation. Transfusion 1998;38:938-43.
20. Heinrich HC. Bioavailability and therapeutic efficiency of oral iron (II)- and -(III) preparations. Schweiz Apotheker-Zeitung 1986;124:1231-56.
21. Alvarez-Ossorio L, Schlenke P. Correspondence "low ferritin levels indicate the need for iron supplementation: strategy to minimize iron-depletion in regular blood donors." Transfusion Med 2001;11:59-60.
22. Devasthali SD, Gordeuk VR, Brittenham GM, et al. Bioavailability of carbonyl iron: a randomized, double-blind study. Eur J Haematol 1991;46:272-8.